- 1 Agni-IV Ballistic Missile Test
- 2 Indian Navy Receives ‘Mangrol’ ASW-SWC
- 3 Machilipatnam: Seventh Mahe-Class Anti-Submarine Warfare Craft
- 4 India Leases Two MQ-9B SeaGuardian Drones
- 5 Indian Navy Inducts Nipun
- 6 Rotating Detonation Engine: A New Leap in Fuel-Efficient Propulsion
- 7 3D Model Could Improve Forecasting of Solar Eruptions
- 8 NASA’s ‘Big Bang’ Fix Gives Voyager 2 Another Year in Interstellar Space
- 9 IN-SPACe Guidelines for Planned Re-entry of Space Objects
- 10 SpaceX Reaches 100 Falcon Missions in 2026
- 11 X1: World’s Largest Fully Battery-Powered Aircraft
- 12 AI Platform MutAIverse Traces Chemicals Linked to DNA Damage
- 13 AI Framework Uncovers Hidden Cancer Stem Cells
- 14 IIT Patna Develops Hybrid Magneto-Rheometer for Smart Fluids
- 15 Light-Activated Nanobots for Targeted Breast Cancer Therapy
- 16 Smart Cancer Drug RK-251
- 17 AI Designs Complete Viral Genomes to Fight Drug-Resistant Bacteria
- 18 Thunderquakes: Using Thunder to Map the Earth’s Subsurface
- 19 Mandatory Vehicle-to-Vehicle Communication
- 20 800 kN FFSC Rocket Engine
- 21 India’s First Indigenous African Swine Fever Vaccine
- 22 Moken Sea Nomads and Underwater Vision
- 23 IUCAA Discovers X-ray Binary System in Magellanic Bridge
- 24 Bio-Inspired Coating for 3D-Printed Bone Implants
- 25 Reusable Rocket Stage Recovery by China
IARC Classifies Three Common Medicines as Group 1 Carcinogens
Recently, the International Agency for Research on Cancer (IARC), the cancer research agency of the WHO, has classified hydrochlorothiazide, voriconazole and tacrolimus as “carcinogenic to humans” (Group 1).
- Hydrochlorothiazide is used to treat high blood pressure and has been linked to squamous cell skin carcinoma and lip cancer, partly due to increased sensitivity to UV radiation.
- Voriconazole, an antifungal medicine, has been associated with squamous cell skin carcinoma, particularly among transplant recipients receiving prolonged treatment.
- Tacrolimus, an immunosuppressant used to prevent organ transplant rejection, has been linked to non-Hodgkin lymphoma and post-transplant lymphoproliferative disorder.
- All three medicines are included in the WHO Model List ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India Approves First Dengue Vaccine
- 2 NeoSep1 Trial for Neonatal Sepsis
- 3 WHO Lists First Ebola BDBV Diagnostic Test
- 4 Mission Drishti Encounters Anomaly After Solar Storm
- 5 ISRO Conducts Gaganyaan IMAT-05 Test
- 6 India Launches Once-Weekly Basal Insulin
- 7 White Rabbit-Based Indian Standard Time Distribution Network
- 8 World's Largest Synchronized Spintronic Network Demonstrated
- 9 CeNS Develops Ultra-Sensitive Ammonia Sensor
- 10 MOF Material Removes Tritium Efficiently
